loadpatents
name:-0.044019937515259
name:-0.053983926773071
name:-0.008152961730957
Weber; Eckard Patent Filings

Weber; Eckard

Patent Applications and Registrations

Patent applications and USPTO patent grants for Weber; Eckard.The latest application filed is for "compositions for affecting weight loss".

Company Profile
6.45.51
  • Weber; Eckard - San Diego CA
  • Weber, Eckard - Laguna Beach CA
  • Weber; Eckard - Portland OR
  • Weber; Eckard - San Francisco CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Compositions For Affecting Weight Loss
App 20220202808 - Weber; Eckard ;   et al.
2022-06-30
Compositions for affecting weight loss
Grant 11,278,544 - Weber , et al. March 22, 2
2022-03-22
Methods For Administering Weight Loss Medications
App 20200352863 - McKinney; Anthony A. ;   et al.
2020-11-12
Treatment of Cancer with TG02
App 20200323862 - ESTOK; Thomas M. ;   et al.
2020-10-15
Methods For Administering Weight Loss Medications
App 20190282503 - McKinney; Anthony A. ;   et al.
2019-09-19
Compositions For Affecting Weight Loss
App 20190216799 - Weber; Eckard ;   et al.
2019-07-18
Methods for administering weight loss medications
Grant 10,307,376 - McKinney , et al.
2019-06-04
Compositions for affecting weight loss
Grant 10,238,647 - Weber , et al.
2019-03-26
Methods For Administering Weight Loss Medications
App 20180360760 - McKinney; Anthony A. ;   et al.
2018-12-20
Compositions For Affecting Weight Loss
App 20170007598 - Weber; Eckard ;   et al.
2017-01-12
Layered Pharmaceutical Formulations
App 20160338965 - McKinney; Anthony A. ;   et al.
2016-11-24
Methods For Administering Weight Loss Medications
App 20160193152 - McKinney; Anthony A. ;   et al.
2016-07-07
Methods for administering weight loss medications
Grant 9,125,868 - McKinney , et al. September 8, 2
2015-09-08
Layered Pharmaceutical Formulations
App 20150164806 - McKinney; Anthony A. ;   et al.
2015-06-18
Compositions For Affecting Weight Loss
App 20150141452 - Weber; Eckard ;   et al.
2015-05-21
Methods For Administering Weight Loss Medications
App 20140322318 - McKinney; Anthony A. ;   et al.
2014-10-30
Methods for administering weight loss medications
Grant 8,722,085 - McKinney , et al. May 13, 2
2014-05-13
Layered Pharmaceutical Formulations
App 20130177602 - McKinney; Anthony A. ;   et al.
2013-07-11
Layered pharmaceutical formulations
Grant 8,318,788 - McKinney , et al. November 27, 2
2012-11-27
Layered Pharmaceutical Formulations
App 20120093889 - McKinney; Anthony ;   et al.
2012-04-19
Compositions For Affecting Weight Loss
App 20120010232 - Weber; Eckard ;   et al.
2012-01-12
Layered pharmaceutical formulations
Grant 8,088,786 - McKinney , et al. January 3, 2
2012-01-03
Methods For Administering Weight Loss Medications
App 20110059170 - McKinney; Anthony ;   et al.
2011-03-10
Method of Decreasing Ubiquitylated Protein Levels
App 20100298348 - Green; Kim Nicholas ;   et al.
2010-11-25
Method of Decreasing Pro-ADAM10 Secretase and/or Beta Secretase Levels
App 20100267763 - GREEN; Kim Nicholas ;   et al.
2010-10-21
Method of Treating Cognitive Impairment
App 20100256173 - WEBER; Eckard
2010-10-07
Compositions For Affecting Weight Loss
App 20100190793 - Weber; Eckard ;   et al.
2010-07-29
Method of Inducing Cleavage of Amyloid Precursor Protein to Form a Novel Fragment
App 20100168135 - Green; Kim Nicholas ;   et al.
2010-07-01
Stabilized formulations of alpha adrenergic receptor antagonists and the uses thereof
Grant 7,575,757 - Chen , et al. August 18, 2
2009-08-18
Stabilized formulations of alpha adrenergic receptor antagonists and the uses thereof
Grant 7,569,230 - Chen , et al. August 4, 2
2009-08-04
Local Anesthetic Methods and Kits
App 20090076023 - WEBER; Eckard ;   et al.
2009-03-19
Compositions for affecting weight loss
Grant 7,462,626 - Weber , et al. December 9, 2
2008-12-09
Compositions for affecting weight loss
Grant 7,375,111 - Weber , et al. May 20, 2
2008-05-20
Methods For Administering Weight Loss Medications
App 20080110792 - McKinney; Anthony ;   et al.
2008-05-15
Layered Pharmaceutical Formulations
App 20080113026 - McKinney; Anthony ;   et al.
2008-05-15
Compositions For Affecting Weight Loss
App 20070275970 - Weber; Eckard ;   et al.
2007-11-29
Compositions For Affecting Weight Loss
App 20070270450 - Weber; Eckard ;   et al.
2007-11-22
Co-administration Of Adenosine A1 Receptor Antagonists And Anticonvulsants
App 20070238672 - Dittrich; Howard ;   et al.
2007-10-11
Fluorogenic or fluorescent reporter molecules and their applications for whole-cell fluorescence screening assays for caspases and other enzymes and the use thereof
Grant 7,270,801 - Weber , et al. September 18, 2
2007-09-18
Local anesthetic methods and kits
Grant 7,261,889 - Weber , et al. August 28, 2
2007-08-28
Stabilized formulations of alpha adrenergic receptor antagonists and the uses thereof
Grant 7,229,630 - Chen , et al. June 12, 2
2007-06-12
Stabilized Formulations of alpha Adrenergic Receptor Antagonists and the Uses Thereof
App 20070098748 - CHEN; Andrew X. ;   et al.
2007-05-03
Compositions for affecting weight loss
App 20060142290 - Weber; Eckard ;   et al.
2006-06-29
Compositions for affecting weight loss
App 20060100205 - Weber; Eckard ;   et al.
2006-05-11
Combination of bupropion and a second compound for affecting weight loss
App 20060058293 - Weber; Eckard ;   et al.
2006-03-16
Dipeptide apoptosis inhibitors and the use thereof
Grant 6,949,516 - Keana , et al. September 27, 2
2005-09-27
Stabilized formulations of alpha adrenergic receptor antagonists and the uses thereof
App 20050203099 - Chen, Andrew X. ;   et al.
2005-09-15
Dipeptide apoptosis inhibitors and the use thereof
App 20050192231 - Keana, John F.W. ;   et al.
2005-09-01
Local anesthetic methods and kits
App 20050165098 - Weber, Eckard ;   et al.
2005-07-28
Local anesthetic methods and kits
App 20050165097 - Weber, Eckard ;   et al.
2005-07-28
Local anesthetic methods and kits
Grant 6,872,390 - Weber , et al. March 29, 2
2005-03-29
Compositions for affecting weight loss
App 20040254208 - Weber, Eckard ;   et al.
2004-12-16
Local anesthetic methods and kits
App 20040198816 - Weber, Eckard ;   et al.
2004-10-07
Novel fluorogenic or fluorescent reporter molecules and their applications for whole-cell fluorescence screening assays for caspases and other enzymes and the use thereof
App 20040191844 - Weber, Eckard ;   et al.
2004-09-30
Local anesthetic methods and kits
Grant 6,764,678 - Weber , et al. July 20, 2
2004-07-20
Fluorogenic or fluorescent reporter molecules and their applications for whole-cell fluorescence screening assays for caspases and other enzymes and the use thereof
Grant 6,759,207 - Weber , et al. July 6, 2
2004-07-06
Caspase inhibitors and the use thereof
App 20040116355 - Cai, Sui Xiong ;   et al.
2004-06-17
Caspase inhibitors and the use thereof
Grant 6,716,818 - Cai , et al. April 6, 2
2004-04-06
Local anesthetic methods and kits
App 20040063747 - Weber, Eckard ;   et al.
2004-04-01
Stabilized formulations of alpha adrenergic receptor antagonists and the uses thereof
App 20040044019 - Chen, Andrew X. ;   et al.
2004-03-04
Stabilized formulations of alpha adrenergic receptor antagonists and the uses thereof
App 20030236306 - Chen, Andrew X. ;   et al.
2003-12-25
Carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones and the use thereof
App 20030225080 - Wang, Yan ;   et al.
2003-12-04
Substituted 2-aminobenzamide caspase inhibitors and the use thereof
App 20030181388 - Cai, Sui Xiong ;   et al.
2003-09-25
Dipeptide apoptosis inhibitors and the use thereof
App 20030181391 - Keana, John F.W. ;   et al.
2003-09-25
Carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones and the use thereof
Grant 6,613,803 - Wang , et al. September 2, 2
2003-09-02
Dipeptide apoptosis inhibitors and the thereof
Grant 6,596,693 - Keana , et al. July 22, 2
2003-07-22
4-Substituted piperidine analogs and their use as subtype selective NMDA receptor, antagonists
App 20030105133 - Bigge, Christopher F. ;   et al.
2003-06-05
Local anesthetic methods and kits
App 20020183356 - Weber, Eckard ;   et al.
2002-12-05
Local anesthetic methods and kits
App 20020183396 - Weber, Eckard ;   et al.
2002-12-05
Novel fluorogenic or fluorescent reporter molecules and their applications for whole-cell fluorescence screening assays for caspases and other enzymes and the use thereof
App 20020150885 - Weber, Eckard ;   et al.
2002-10-17
Local anesthetic methods and kits
Grant 6,432,401 - Weber , et al. August 13, 2
2002-08-13
Caspase inhibitors and the use thereof
App 20020058631 - Cai, Sui Xiong ;   et al.
2002-05-16
Caspase inhibitors and the use thereof
Grant 6,355,618 - Cai , et al. March 12, 2
2002-03-12
Fluorogenic or fluorescent reporter molecules and their applications for whole-cell fluorescence screening assays for capsases and other enzymes and the use thereof
Grant 6,342,611 - Weber , et al. January 29, 2
2002-01-29
Local anesthetic methods and kits
App 20010056125 - Weber, Eckard ;   et al.
2001-12-27
Tri-and tetra-substituted guanidines and their use as excitatory amino acid antagonists
Grant 6,251,948 - Weber , et al. June 26, 2
2001-06-26
Dipeptide caspase inhibitors and the use thereof
Grant 6,153,591 - Cai , et al. November 28, 2
2000-11-28
4-substituted piperidine analogs and their use as subtype selective NMDA receptor antagonists
Grant 6,130,234 - Bigge , et al. October 10, 2
2000-10-10
4-substituted piperidine analogs and their use as subtype selective NMDA receptor antagonists
Grant 6,124,323 - Bigge , et al. September 26, 2
2000-09-26
2-substituted piperidine analogs and their use as subtype-selective NMDA receptor antagonists
Grant 6,124,317 - Bigge , et al. September 26, 2
2000-09-26
Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones
Grant 5,631,373 - Cai , et al. May 20, 1
1997-05-20
Glycine receptor antagonists and the use thereof
Grant 5,620,979 - Weber , et al. April 15, 1
1997-04-15
Glycine receptor antagonist pharmacophore
Grant 5,597,922 - Cai , et al. January 28, 1
1997-01-28
Glycine receptor antagonists and the use thereof
Grant 5,514,680 - Weber , et al. May 7, 1
1996-05-07
Substituted guanidines having high binding to the sigma receptor and the use thereof
Grant 5,502,255 - Keana , et al. March 26, 1
1996-03-26
1,2,3,4-tetrahydroquinoline-2,3,4-trione-3 or 4-oximes and the use thereof
Grant 5,475,007 - Cai , et al. December 12, 1
1995-12-12
Method for treating hypertension with disubstituted granidine compounds
Grant 5,385,946 - Keana , et al. January 31, 1
1995-01-31
Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists
Grant 5,336,689 - Weber , et al. August 9, 1
1994-08-09
Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists
Grant 5,262,568 - Weber , et al. November 16, 1
1993-11-16
N,N'-disubstituted guanidines and their use as excitatory amino acid antagonists
Grant 5,190,976 - Weber , et al. March 2, 1
1993-03-02
N,N'-disubstituted guanidines and their use as excitatory amino acid antagonists
Grant 5,093,525 - Weber , et al. March 3, 1
1992-03-03
CNQX and its analogs as therapeutics for degenerative neural diseases
Grant 4,975,430 - Jahr , et al. December 4, 1
1990-12-04
N,N'-disubstituted guanidines and their use as excitatory amino acid antagonists
Grant 4,906,779 - Weber , et al. March 6, 1
1990-03-06
Sigma brain receptor ligands and their use
Grant 4,709,094 - Weber , et al. November 24, 1
1987-11-24
Gastrin releasing peptide-like peptides
Grant 4,613,586 - Barchas , et al. September 23, 1
1986-09-23
Company Registrations
SEC0001279800WEBER ECKARD

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed